Friday, November 23, 2012

• Sarepta Therapeutics: Tomorrow's Monster Stockat Motley Fool (Fri, Nov 23)
• Traders pin hopes on new Keryx drugoptionMONSTER (Fri, Nov 23)

Wednesday, November 21, 2012

• Keryx Is Completely Misunderstood And May Double On Dataat Seeking Alpha (Wed, Nov 21)

Tuesday, November 20, 2012

• Is It Time To Look At Keryx Again?at Seeking Alpha (Tue, Nov 20)
• Improving Trend in FDA First Cycle Review Approvals a Major Factor for Biotech Industry's Success in 2012Marketwired (Tue, Nov 20)

Thursday, November 8, 2012

• Keryx Biopharmaceuticals' CEO Discusses Q3 2012 Results - Earnings Call Transcriptat Seeking Alpha (Thu, Nov 8)
• KERYX BIOPHARMACEUTICALS INC Files SEC form 10-Q, Quarterly ReportEDGAR Online (Thu, Nov 8)
• PhotoMedex Expected to Gain Market Share and 2 Stock Analyses to See Nowat Wall St. Cheat Sheet (Thu, Nov 8)

Wednesday, November 7, 2012

• KERYX BIOPHARMACEUTICALS INC Files SEC form 8-K, Results of Operations and Financial Condition, Other Events, FinanciEDGAR Online (Wed, Nov 7)
• Keryx Biopharmaceuticals reports Q3 EPS (8c), consensus (7c)theflyonthewall.com (Wed, Nov 7)

Tuesday, November 6, 2012

• Neuralstem Is Speculative, But Its Work In Stem Cell Therapy Can't Be Ignoredat Seeking Alpha (Tue, Nov 6)

Friday, October 26, 2012

• Biotech Stock Mailbag: Catalyst Pharma, Amarin, Star Scientificat TheStreet (Fri, Oct 26)

Wednesday, October 24, 2012

• Smaller, Faster Clinical Trials Considered by the FDA for Developers of Critical Drugs and TreatmentsMarketwired (Wed, Oct 24)

Friday, October 19, 2012

• A Refreshing Outlook - Consensus Reports on Keryx Biopharmaceuticals, Inc. and Momenta Pharmaceuticals, Inc.Marketwired (Fri, Oct 19)

Thursday, October 18, 2012

• Another Day, Another Biotech Dilutionat Motley Fool (Thu, Oct 18)

Monday, October 15, 2012

• Confounding Combo Dataat Motley Fool (Mon, Oct 15)
• Biotech Investors: Are We Blinded By Clinical Trials?at Seeking Alpha (Mon, Oct 15)

Thursday, October 11, 2012

• Keryx Continues Its Lengthy Bull Runat Seeking Alpha (Thu, Oct 11)

Wednesday, October 10, 2012

• Susser Reiterated at Buy and 4 Reiterated Ratings to Recognizeat Wall St. Cheat Sheet (Wed, Oct 10)
• Chevron’s Estimates Lowered Below Consensus and 4 Stock Analyses Making Headlinesat Wall St. Cheat Sheet (Wed, Oct 10)
• 3 Stocks to Get on Your Watchlistat Motley Fool (Wed, Oct 10)

Sunday, October 7, 2012

• Aeterna Zentaris Casts a Lifelineat Motley Fool (Sun, Oct 7)

Thursday, October 4, 2012

• Biotech Industry Look to Benefit From New Act Designed to Promote R&D Joint VenturesMarketwired (Thu, Oct 4)

Tuesday, October 2, 2012

• Long-Term BioTech Playat Motley Fool (Tue, Oct 2)

Tuesday, September 25, 2012

• Smaller Cap Biopharma News And Events For Tuesday, September 25at Seeking Alpha (Tue, Sep 25)

Add KERX News to My Yahoo!